Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Evolent Health, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $4.46B | $4.20B - $4.69B | $154.80M | $0.83 | 3 |
| Dec 2029 | $3.94B | $3.71B - $4.15B | $136.92M | $0.70 | 5 |
| Dec 2028 | $3.34B | $3.34B - $3.34B | $115.88M | $0.466 | 6 |
| Dec 2027 | $2.94B | $2.68B - $3.16B | $101.99M | $0.385 | 12 |
| Dec 2026 | $2.49B | $2.46B - $2.51B | $86.61M | $0.174 | 12 |
| Dec 2025 | $1.88B | $1.87B - $1.89B | $65.16M | $0.064 | 10 |
| Dec 2024 | $2.56B | $2.55B - $2.69B | $88.88M | $0.707 | 10 |
| Dec 2023 | $2.35B | $2.22B - $2.48B | $81.74M | -$0.934 | 5 |
| Dec 2022 | $1.34B | $1.27B - $1.39B | -$39.23M | $0.861 | 6 |
| Dec 2021 | $890.15M | $843.68M - $923.48M | $128.24M | -$0.037 | 7 |
| Dec 2020 | $1.01B | $959.27M - $1.05B | -$340.54M | -$0.243 | 7 |
| Dec 2019 | $844.15M | $800.08M - $875.75M | -$234.71M | -$0.691 | 6 |